Prevalence and difficulties in chronic obstructive pulmonary disease diagnosis in patients suffering from severe peripheral arterial disease;Czȩstosc wystȩpowania oraz trudnosci w diagnozowaniu POChP u chorych na zaawansowana̧ miażdżycȩ zarostowa̧ tȩtnic kończyn dolnych

Polski Merkuriusz Lekarski

Volumn 27, Issue 158, 2009, Pages 92-96

  Justyna, Śleszycka ^a   Krzysztof, Woźniak ^a   Marta, Banaszek ^a   Wiechno, Wiesław ^a   Joanna, Domagała Kulawik ^a  

^a MEDICAL UNIVERSITY OF WARSAW   (Poland)

Author keywords

Chronic obstructive pulmonary disease; Diagnostics; Peripheral arterial disease; Spirometry

Indexed keywords

EID: 70349604530     PISSN: 14269686     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. (Pubitemid 29296676) Bestall J., Paul E., Garrod R. i wsp.: Usefullness of the Medical Research Council (MRC) dyspnea scale as a measure of disability in patients with chronic obstructive pulmonary disease. T. Thorax., 1999, 54 (7), 581-586.
2. (Pubitemid 38269277) Celli B., Cote C., Marin J. i wsp.: The body-mass index, airflow obstruction, dyspnea, and exercise capacity index in chronic obstructive pulmonary disease. N. N. Eng. J. Med., 2004, 350 (10), 1005-1012.
3. (Pubitemid 46446859) Cote C., Dordelly L., Celli B.: Impact of COPD exacerbations on patientcentered outcomes. Chest., 2007, 131 (3), 696-704.
4. (Pubitemid 35178607) Donaldson G., Seemungal T., Bhowmik A. i wsp.: Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax, 2002, 57, 847-852.
5. Dormandy J., Rutherford R. i wsp.: TransAtlantic Inter-Society Consensus (TASC). Management of peripheral arterial disease (PAD). J. Vasc. Surg., 2000, 31, 1-296.
6. Global Strategy for Asthma Management and Prevention, Global Initiative for Asthma (GINA) 2007. Available from: http://www.ginasthma.org/ (accessed Dec. 2008).
7. Global Initiative for Chronic Obstructive Lung Disease. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease. Updated November 2008. Available from: http://www.goldcopd.com/ (accessed Dec. 2008).
8. (Pubitemid 43853480) Hirsch A., Haskal Z., Hertzer N.: ACC/AHA 2005 guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic). J. J. Am. Coll. Cardiol., 2006, 47 (6), 1239-312ACC/AHA.
9. Hodgev V., Kostianev S., Marinov B.: Correlation of frequency of exacerbations with the BODE index in COPD patients. Folia. Med. (Plovdiv)., 2006, 48 (2), 18-22.
10. Jassó I., Landi A., Dinya E.: Risk status of patients with peripheral arterial disease (PAD). Orv. Hetil., 2007, 148 (52), 2469-2476.
11. Kesten S., Casaburi R., Kukafka D. i wsp.: Improvement in self-reported exercise participation with the combination of tiotroium and rehabilitative exercise training in COPD patients. I. Int. J. Chron. Obstruct. Pulmon. Dis., 2008, 3 (1), 127-136.
12. (Pubitemid 46054390) Le Jemtel T., Padeletti M., Jelic S.: Diagnostic and therapeutic challenges in patients with coexistent chronic obstructive pulmonary disease and chronic heart failure. J. J. Am. Coll. Cardiol., 2007, 49 (2), 171-180.
13. Lundbäck B., Gulsvik A., Alters M. i wsp.: Epidemiological aspects and early detection of chronic obstructive airway diseases in the elderly. Eur. Respir. J. Suppl., 2003, 40, 3-9.
14. (Pubitemid 36284990) Lundbäck B., Lindberg A., Lindström M. i wsp.: Not 15 but 50% of smokers develop COPD? - Report from the Obstructive Lung Disease in Northern Sweden Studies. Respir. Med., 2003, 97 (2), 115-122.
15. (Pubitemid 40562961) MacCallum P.: Markers of hemostasis and systemic inflammation in heart disease and atherosclerosis in smokers. Proc. Am. Thorac. Soc., 2005, 2, 34-43.
16. Marin J., Carrizo S., Casanova C. i wsp.: Prediction of risk of COPD exacerbations by the BODE index. Respir. Med., 2008, Nov. 13.
17. (Pubitemid 29473300) Ness J., Aronow W.: Prevalence of coexistence of coronary artery disease, ischemic stroke, and peripheral arterial disease in older persons, mean age 80 years, in an academic hospital-based geriatrics practice. J. J. Am. Geriatr. Soc., 1999, 47 (10), 1255-1256.
18. (Pubitemid 38009677) Pływaczewski R., Bednarek M., Jonczak L. i wsp.: Prevalence of COPD in Warsaw population. Pneumonol. Alergol. Pol., 2003, 71 (7-8), 329-335.
19. (Pubitemid 44635314) Rutten F., Cramer M., Lammers J. i wsp.: Heart failure and chronic obstructive pulmonary disease: An ignored combination? Eur. J. Heart. Fail., 2006, 8 (7), 706-711.
20. (Pubitemid 350221678) Salepçi B., Eren A., Caglayan B.: The effect of body mass index on functional parameters and quality of life in COPD patients. Tuberk. Toraks., 2007, 55 (4), 342-349.
21. (Pubitemid 36378490) Sin D., Man S.: Why are patients with chronic obstructive pulmonary disease at increased risk of cardiovascular diseases? The potential role of systemic inflammation in chronic obstructive pulmonary disease., Circulation., 2003, 25, 107 (11), 1514-1519.
22. Tashkin D., Celli B., Decramer M. i wsp.: Bronchodilator responsiveness in patients with COPD. Eur. Respir. J., 2008, 31 (4), 742-750.
23. (Pubitemid 44914210) Zieliński J., Bednarek M., Górecka D. i wsp.: Increasing COPD awareness. Eur. Respir. J., 2006, 27 (4), 833-852.
24. (Pubitemid 43273932) Zieliński J., Bednarek M., Górecka D. i wsp.: National Program of Early Detection and Prevention of COPD in the years 2000-2002. Pneumonol. Alergol. Pol., 2005, 73 (2), 116-121.